Pacific Biosciences of California Inc at JPMorgan Healthcare Conference Transcript
&-
Perfect. Good afternoon, everyone. This is Rachel Vatnsdal from the life science tools and diagnostics team here at JPMorgan. I'm joined by Christian Henry, President and CEO, PacBio. And so as you've typically seen with most of these sessions, that will be 40 minutes roughly 20 minutes of a presentation followed by 20 minutes of Q&A, if any of you in the room do questions, feel free to either submit them via the portal or you can send them to me directly? And with that, I will pass it off to Christian.
Thank you, Rachel, and thank you, JPM, for the opportunity to present in front of all of you today. Also, thank you to all of you for for your attention and your interest in PacBio.
Before we get started, I want to remind folks that we do have we might be making some forward-looking statements, so please refer to our SEC filings as well.
As our website to learn more about the risks and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |